Cipher Pharmaceuticals Cipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products Products Cipher develops and acquires best-in-class products for unmet medical needsPipeline Phase III studies are underway for two Cipher product candidatesInvestor Presentation Stock Information Financial Reports Corporate Governance Recent News Jun. 18, 2026 Cipher Pharmaceuticals Announces Results of Annual General Meeting of ShareholdersMay. 07, 2026 Cipher Pharmaceuticals Reports First Quarter ResultsSee more releasesOur team is continually evaluating businesses with commercial products, proven capabilities or where synergies exist with our current product offerings for merger or acquisition opportunities Business Development
